Skip to content

To study the safety and efficacy of disposable cyclone ring in artificial abortion

To study the safety and efficacy of disposable cyclone ring in artificial abortion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089857
Enrollment
Unknown
Registered
2024-09-18
Start date
2024-09-18
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

abortion

Interventions

Rotary induced abortion:Rotary induced abortion under ultrasonic monitoring was performed with intravenous anesthesia.
Negative pressure electrosuction induced abortion:The procedure was performed under ultrasonic monitoring and intravenous anesthesia.

Sponsors

Peking Union Hospital, Chinese Academy of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Age: 20-40 years old, planning to terminate pregnancy; 2) Menopause time= 56 days (8 weeks); 3) Ultrasound examination showed early pregnancy in utero, and the average diameter of the fetal sac was 1-3cm; 4) According to the requirements of clinical operation standards, the preoperative examination, laboratory results and surgical indicators are normal 5) The subject was conscious, had good compliance, agreed to participate in the trial, and voluntarily signed the informed consent form

Exclusion criteria

Exclusion criteria: 1) According to the requirements of clinical practice, there are contraindications to induced abortion; 2) The number of previous induced abortions =2 times; 3) Diseases affecting uterine cavity morphology such as uterine malformations and uterine fibroids; 4) History of uterine surgery: such as submucosal myomectomy history, mediastinal resection history, uterine adhesion-separation history; 5) Unable to sign the informed consent; 6) Other conditions that the investigator considers inappropriate to participate in this clinical study.

Design outcomes

Primary

MeasureTime frame
Cervical dilation rate (e.g. %);Comparison of uterine cavity residual rate (case %) at 3 weeks postoperatively;Complication rate;

Secondary

MeasureTime frame
Intraoperative blood loss (ml);Endometrial thickness at 3 weeks postoperatively;Menstrual recovery;Incidence of adverse events;

Countries

China

Contacts

Public ContactLiuxinyan

Peking Union Hospital, Chinese Academy of Medical Sciences

liuxymeng@163.com+86 186 0000 8013

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026